AKESO ANNOUNCES OPENING OF GLOBAL PHASE II STUDY OF IVONESCIMAB IN FIRST-LINE CLEAR CELL RENAL CELL CARCINOMA, INCLUDING COMBINATION WITH CADONILIMAB

Reuters · 6d ago

Please log in to view news